Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$111.65M
Total Bought:
$41.98M
Total Sold:
$60.77M
Net Transaction:
-$18.79M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
BridgeBio Pharma, Inc.(BBIO)246,700165,496-81,204$6.77M$5.72M5.12%-$1.05M
Guardant Health, Inc.(GH)147,800127,182-20,618$4.52M$5.42M4.85%+$902.7K
Geron Corporation(GERN)1,561,1523,215,457+1,654,305$5.62M$5.11M4.58%-$510.1K
AstraZeneca PLCADR(AZN)032,534+32,534$0$4.73M4.23%+$4.73M
Cytokinetics, Incorporated(CYTK)65,883103,483+37,600$3.10M$4.16M3.73%+$1.06M
Syndax Pharmaceuticals, Inc.(SNDX)318,900337,198+18,298$4.22M$4.14M3.71%-$73.4K
Ionis Pharmaceuticals, Inc.(IONS)61,367135,616+74,249$2.15M$4.09M3.66%+$1.95M
Eli Lilly and Company(LLY)8,2474,673-3,574$6.37M$3.86M3.46%-$2.51M
Cogent Biosciences, Inc.(COGT)0621,678+621,678$0$3.72M3.34%+$3.72M
Intuitive Surgical, Inc.(ISRG)7,4276,358-1,069$3.88M$3.15M2.82%-$727.7K
Soleno Therapeutics Inc77,28543,441-33,844$3.47M$3.10M2.78%-$370.1K
Akero Therapeutics Inc68,60876,379+7,771$1.91M$3.09M2.77%+$1.18M
Disc Medicine, Inc.(IRON)69,07261,656-7,416$4.38M$3.06M2.74%-$1.32M
Viridian Therapeutics, Inc.(VRDN)0217,294+217,294$0$2.93M2.62%+$2.93M
REGENXBIO Inc.(RGNX)0405,281+405,281$0$2.90M2.60%+$2.90M
Replimune Group, Inc.(REPL)54,738294,846+240,108$662.9K$2.87M2.57%+$2.21M
Scholar Rock Holding Corporation(SRRK)77,43984,339+6,900$3.35M$2.71M2.43%-$635.4K
Dyne Therapeutics, Inc.(DYN)0258,391+258,391$0$2.70M2.42%+$2.70M
Natera, Inc.(NTRA)22,45018,650-3,800$3.55M$2.64M2.36%-$916.5K
89bio Inc225,323353,882+128,559$1.76M$2.57M2.30%+$810.7K
Penumbra, Inc.(PEN)9,0009,0000$2.14M$2.41M2.16%+$269.4K
Savara Inc.(SVRA)699,698836,397+136,699$2.15M$2.32M2.08%+$168.7K
Anaptysbio Inc0116,623+116,623$0$2.17M1.94%+$2.17M
Travere Therapeutics, Inc.(TVTX)0118,017+118,017$0$2.11M1.89%+$2.11M
Centessa Pharmaceuticals PlcADS137,716142,744+5,028$2.31M$2.05M1.84%-$254.1K
GE HealthCare Technologies Inc.(GEHC)025,400+25,400$0$2.05M1.84%+$2.05M
Fulcrum Therapeutics, Inc.(FULC)283,599689,137+405,538$1.33M$1.98M1.78%+$651.8K
Structure Therapeutics IncADS151,965102,944-49,021$4.12M$1.78M1.60%-$2.34M
Immunome, Inc.(IMNM)0263,841+263,841$0$1.78M1.59%+$1.78M
BeOne Medicines AGADS(ONC)10,0006,500-3,500$1.85M$1.77M1.58%-$78.0K
Crinetics Pharmaceuticals In051,295+51,295$0$1.72M1.54%+$1.72M
Edgewise Therapeutics, Inc.(EWTX)81,47371,438-10,035$2.18M$1.57M1.41%-$603.7K
Dr. Reddy's Laboratories LimitedADR(RDY)117,500117,5000$1.86M$1.55M1.39%-$305.5K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0289,690+289,690$0$1.54M1.38%+$1.54M
Karyopharm Therapeutics IncNOTE 3 000 10 12,000,0002,000,0000$1.56M$1.52M1.36%-$33.6K
Nektar Therapeutics(NKTR)618,1742,232,453+1,614,279$574.9K$1.52M1.36%+$943.2K
Arvinas, Inc.(ARVN)218,700195,295-23,405$4.19M$1.37M1.23%-$2.82M
Gossamer Bio, Inc.(GOSS)1,097,9991,097,9990$993.3K$1.21M1.08%+$214.5K
Trevi Therapeutics, Inc.(TRVI)0163,738+163,738$0$1.03M0.92%+$1.03M
MBX Biosciences, Inc.(MBX)0133,113+133,113$0$982.4K0.88%+$982.4K
Biohaven Ltd.(BHVN)28,15939,900+11,741$1.05M$959.2K0.86%-$92.5K
Alvotech(ALVO)90,10090,1000$1.19M$871.3K0.78%-$320.8K
Yarrow Bioscience Inc(YARW)353,434462,801+109,367$1.18M$731.2K0.65%-$452.8K
Establishment Labs Holdings Inc.(ESTA)13,10013,1000$603.5K$534.5K0.48%-$69.0K
BioCryst Pharmaceuticals, Inc.(BCRX)060,600+60,600$0$454.5K0.41%+$454.5K
Eledon Pharmaceuticals, Inc.(ELDN)256,373114,145-142,228$1.06M$387.0K0.35%-$669.3K
Akebia Therapeutics, Inc.(AKBA)205,956189,087-16,869$391.3K$363.0K0.33%-$28.3K
Nuvation Bio Inc.CL A(NUVB)096,311+96,311$0$169.5K0.15%+$169.5K
Aprea Therapeutics, Inc.(APRE)127,96028,972-98,988$419.7K$59.1K0.05%-$360.6K
Acelyrin Inc234,4350-234,435$736.1K$0—-$736.1K
Aclaris Therapeutics, Inc.(ACRS)389,3330-389,333$965.5K$0—-$965.5K
Annexon, Inc.(ANNX)144,8300-144,830$743.0K$0—-$743.0K
Apellis Pharmaceuticals Inc
COM
119,4670-119,467$3.81M$0—-$3.81M
Arbutus Biopharma Corporation(ABUS)28,3000-28,300$92.5K$0—-$92.5K
Blueprint Medicines Corp31,8000-31,800$2.77M$0—-$2.77M
Boston Scientific Corporation(BSX)40,5000-40,500$3.62M$0—-$3.62M
Bristol-Myers Squibb Company(BMY)65,2000-65,200$3.69M$0—-$3.69M
Gilead Sciences, Inc.(GILD)29,7000-29,700$2.74M$0—-$2.74M
Humana Inc.(HUM)18,0660-18,066$4.58M$0—-$4.58M
Janux Therapeutics, Inc.(JANX)40,1230-40,123$2.15M$0—-$2.15M
Cypherpunk Technologies Inc.(CYPH)102,6310-102,631$295.1K$0—-$295.1K
Legend Biotech CorporationADS(LEGN)37,6000-37,600$1.22M$0—-$1.22M
Madrigal Pharmaceuticals, Inc.(MDGL)9870-987$304.6K$0—-$304.6K
Mersana Therapeutics Inc172,9240-172,924$249.7K$0—-$249.7K
Nuvalent Inc40,5800-40,580$3.19M$0—-$3.19M
Pliant Therapeutics, Inc.(PLRX)103,5040-103,504$1.36M$0—-$1.36M
Relay Therapeutics, Inc.(RLAY)1,083,4870-1,083,487$4.46M$0—-$4.46M
Rocket Pharmaceuticals, Inc.(RCKT)159,5520-159,552$2.01M$0—-$2.01M
Stoke Therapeutics, Inc.(STOK)113,0960-113,096$1.25M$0—-$1.25M
Summit Therapeutics Inc.(SMMT)130,4120-130,412$2.33M$0—-$2.33M
Tarsus Pharmaceuticals, Inc.(TARS)28,1780-28,178$1.56M$0—-$1.56M
Tectonic Therapeutic, Inc.(TECX)26,0810-26,081$1.20M$0—-$1.20M
Veru Inc.(VERU)1,117,6000-1,117,600$739.5K$0—-$739.5K
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q1 2025 | TickerTrail